XML 73 R62.htm IDEA: XBRL DOCUMENT v3.24.2.u1
SEGMENT AND ENTERPRISE-WIDE INFORMATION (Details)
$ in Thousands
3 Months Ended
Jun. 29, 2024
USD ($)
segment
Jul. 01, 2023
USD ($)
Segment Reporting Information [Line Items]    
Number of reportable segments | segment 3  
Net revenues before foreign exchange impact $ 337,287 $ 311,088
Effect of exchange rates (1,115) 244
Net revenues 336,172 311,332
Operating income 39,756 53,659
Effect of exchange rates (1,349) 2,613
Restructuring Costs (4,622) 11
Restructuring related costs 2,518 2,204
Digital transformation costs 6,345 3,705
Impairment of assets and PCS2 related charges 0 141
Integration and transaction costs (12,323) (1,115)
Amortization of acquired intangible assets 12,471 7,473
Amortization of fair value inventory step-up 5,239 0
MDR and IVDR costs (1,126) (1,166)
Litigation-related charges (755) (1,058)
Gain on sale of assets 14,134 0
United States    
Segment Reporting Information [Line Items]    
Net revenues 248,902 237,073
Japan    
Segment Reporting Information [Line Items]    
Net revenues 13,705 11,773
Europe    
Segment Reporting Information [Line Items]    
Net revenues 47,225 39,387
Rest of Asia    
Segment Reporting Information [Line Items]    
Net revenues 19,783 22,040
Other    
Segment Reporting Information [Line Items]    
Net revenues 6,557 1,059
Plasma    
Segment Reporting Information [Line Items]    
Net revenues before foreign exchange impact 136,042 139,491
Restructuring related costs 175 169
Plasma | Plasma products and services    
Segment Reporting Information [Line Items]    
Net revenues 135,910 139,621
Blood Center    
Segment Reporting Information [Line Items]    
Net revenues before foreign exchange impact 66,839 69,169
Restructuring related costs 43 45
Blood Center | Blood Center products and services    
Segment Reporting Information [Line Items]    
Net revenues 66,245 69,206
Whole Blood, Blood Center | Blood Center products and services    
Segment Reporting Information [Line Items]    
Net revenues 17,151 20,040
Apheresis, Blood Center | Blood Center products and services    
Segment Reporting Information [Line Items]    
Net revenues 49,094 49,166
Hospital    
Segment Reporting Information [Line Items]    
Net revenues before foreign exchange impact 134,406 102,428
Restructuring related costs 108 49
Hospital | Hospital products and services    
Segment Reporting Information [Line Items]    
Net revenues 134,017 102,505
Hemostasis Management, Hospital | Hospital products and services    
Segment Reporting Information [Line Items]    
Net revenues 70,973 64,885
Vascular Closure, Hosptial | Hospital products and services    
Segment Reporting Information [Line Items]    
Net revenues 63,044 37,620
Operating Segments    
Segment Reporting Information [Line Items]    
Operating income 142,350 142,924
Operating Segments | Plasma    
Segment Reporting Information [Line Items]    
Operating income 65,837 75,698
Operating Segments | Blood Center    
Segment Reporting Information [Line Items]    
Operating income 22,622 26,283
Operating Segments | Hospital    
Segment Reporting Information [Line Items]    
Operating income 53,891 40,943
Corporate    
Segment Reporting Information [Line Items]    
Operating income $ 69,980 $ 75,309